Nurs Health Sci
10.1139/apnm-2016-0651 [DOI] [PubMed] [Google Scholar] Lutz J
Oncogene 30 , 907921 (2011)
(2) Dosage and timing: determining the appropriate dosage of UA and the timing of treatment poses a challenge, as UA may exert different effects at varying concentrations, and the timing of treatment is crucial for intervention in neurodegenerative diseases
A 2003 prospective cohort study by Khavinson and Morozov found that epithalon had the following effects when administered to a sample of 266 adults over the age of 60 [9]: Decreased incidence of ischemic heart disease Decreased incidence of hypertension disease Lowered rates of deforming osteoarthritis and osteoporosis More recently, a 2020 study by Khavinson et al
Cheng H, Wang P, Wang N, Dong W, Chen Z, Wu M, Wang Z, Yu Z et al (2023) Neuroprotection of NRF2 against ferroptosis after traumatic brain injury in mice